MedPlus Health Services’ shares jumped 8% after the company reported robust financial performance for the quarter ending December 31, 2024. As of 9:36AM, the shares were trading 7.90% higher at Rs 781.35.
For Q3 FY25, MedPlus posted a total income of ₹1,573.96 crore, reflecting an 8.4% year-on-year (YoY) increase from ₹1,451.57 crore in Q3 FY24. This growth was largely fueled by operational revenue, which rose to ₹1,561.44 crore from ₹1,441.72 crore last year.
The company’s net profit surged by over 240% YoY, reaching ₹45.87 crore, compared to ₹13.37 crore in the same quarter last year. This remarkable increase was largely attributed to cost-control measures, particularly in inventory and materials management.
Other key highlights include a 6.0% rise in total expenses, which reached ₹1,517.36 crore, and a significant increase in profit before tax (PBT), rising to ₹56.60 crore from ₹19.96 crore YoY. Additionally, MedPlus benefitted from a deferred tax credit of ₹4.79 crore.
For the nine months ending December 31, 2024, the company’s total income reached ₹4,659.27 crore, up from ₹4,163.91 crore last year, signaling continued strong growth.
Medplus Health Services shares opened today at ₹750.00 and reached a high of ₹794.00. The stock’s 52-week low stands at ₹598.60, while its 52-week high is ₹875.65. With the previous close at ₹723.35, Medplus shows notable fluctuation, indicating market interest.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
